Salarius Pharmaceuticals Prices $7 Million Public Offering

MT Newswires Live11-12

Salarius Pharmaceuticals (SLRX) said Tuesday it has priced an underwritten public offering of securities to raise about $7 million.

The offering is comprised of about 2.5 million shares and pre-funded warrants to purchase some 2.2 million shares, in each case with accompanying series A and series B warrants to buy up to around 4.7 million shares, the company said.

The offering price is $1.50 per share and accompanying warrants, Salarius said. It expects to close the offering Nov. 12.

Net proceeds will be used for clinical development, promissory notes repayment, and for general corporate purposes, it said.

Shares of Salarius were down about 46% in recent trading.

Price: 1.00, Change: -1.00, Percent Change: -50.00

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment